The Scientist - Home

Coupling a diet low in calories, sugar, and protein with existing cancer drugs treats triple-negative breast cancer in mice, and low blood glucose is associated with better cancer outcomes in human patients.

Percy Lavon Julian, a young, Black scientist working in Jim Crow America, gained international recognition after beating chemists at the University of Oxford in the race to synthesize the alkaloid physostigmine, used for decades as a treatment for glaucoma.

A new link between inflammation and rampant chromosomal abnormalities reveals novel strategies to treat diverse malignancies.

The glossy shell of some beetles, it has long been speculated, helps hide the insects from predators. A recent paper put the hypothesis to the test—and found it wanting.

A new study has identified a molecular tradeoff between growth and immunity in moths in response to the administration of subtherapeutic doses of antibiotics, a common practice in animal husbandry.

Scientists in Canada trace how aquatic communities change as Quebec’s Romaine River flows into the sea.

Reaching a science skeptic is not a matter of credentials; it’s a matter of heart.

Three studies that analyzed samples from Wuhan’s Huanan Seafood Wholesale Market add to evidence that SARS-CoV-2 has zoonotic origins.

The vaccine’s effectiveness in children ages 5 to 11 rapidly declined over the course of a month, according to new research that looked at the health outcomes of hundreds of thousands of children in New York during the Omicron surge.

The CDC has given the OK to lift indoor mask mandates in much of the US, and a growing number of states no longer require face coverings in schools. But most experts agree that masks slow school spread of SARS-CoV-2, and whether now is the right time to allow teachers and students to unmask is a matter of debate.

Canada has ordered 76 million doses of Covifenz, the main ingredient of which was manufactured in the leaves of a tobacco relative.

Denmark’s Novo Nordisk Foundation says it hopes that adding a randomization step to its award process will reduce implicit biases in selection and lead to funding more innovative, impactful research.